U.S. Orders: Processing & Shipping as Normal.Read More
Logo
174 people bought recently
Zoom

Resof Total (Sofosbuvir & Velpatasvir) 400/100mg 28 Tablets

Generic
Be the first to write a review
Active ingredient:Sofosbuvir and Velpatasvir

USD $468.00

Resof Total (Sofosbuvir & Velpatasvir) 400/100mg is a potent antiviral medication designed to treat chronic Hepatitis C. This combination therapy targets the virus, helping to clear infection and improve liver health. With 28 tablets per pack, it offers a comprehensive treatment plan to support your journey towards a virus-free life.
1

Compare Medicines With the Same Generic Name

Products matching the full generic name: Sofosbuvir and Velpatasvir

Share

Active ingredient
Sofosbuvir and Velpatasvir
Pack Qty
28
Pack Size
Tablet
Prescription
Required (Rx)
Dispensing Country
IndiaIndia

Resof Total (Sofosbuvir and Velpatasvir Combination Tablets) - Medicine Description

Sofosbuvir and Velpatasvir Combination Tablets are used in the treatment of chronic Hepatitis C virus (HCV) infection in adults. Marketed under the brand name Epclusa, this combination drug provides a comprehensive treatment option for all genotypes of the Hepatitis C virus, making it a versatile choice for patients with or without cirrhosis. The combination includes Sofosbuvir and Velpatasvir, two potent direct-acting antivirals that work together to stop the virus from replicating and promote viral clearance from the body.


Drug Class:

  • Drug Class: Direct-acting Antivirals (DAA)
  • Categories: Antiviral Agent, Hepatitis C Treatment

Active Ingredient Name:

  • Active Ingredients: Sofosbuvir (400 mg) and Velpatasvir (100 mg)

Popular and Other Names:

  • Brand Name: Epclusa
  • Generic Name: Sofosbuvir and Velpatasvir
  • Other Names: Sofosbuvir-Velpatasvir Tablets

Mode of Action:

The combination of Sofosbuvir and Velpatasvir works synergistically to inhibit the replication of the Hepatitis C virus:

  • Sofosbuvir is a nucleotide analog inhibitor of the NS5B RNA-dependent RNA polymerase enzyme, which is critical for viral RNA replication.
  • Velpatasvir is an NS5A inhibitor that disrupts the assembly and replication of the virus. Together, they block the viral lifecycle at multiple stages, preventing the virus from multiplying and reducing the viral load in the body.

How to Use It:

Sofosbuvir and Velpatasvir combination tablets are taken orally, once daily, with or without food. The tablets should be swallowed whole without chewing, crushing, or breaking them.


Recommended Dosage:

  • Standard Dosage: One tablet (Sofosbuvir 400 mg + Velpatasvir 100 mg) once daily for 12 weeks.
  • Special Considerations: For patients with decompensated cirrhosis, the combination is usually administered with ribavirin for 12 weeks. Dosage adjustments are based on patient condition and treatment response.

Directions:

  • Take the medication at the same time each day to maintain consistent levels in the blood.
  • Do not skip doses or discontinue use without consulting your healthcare provider, as this may lead to drug resistance or treatment failure.
  • If you miss a dose, take it as soon as you remember. If it’s almost time for the next dose, skip the missed dose and resume your regular schedule.

Cautions:

  • Pregnancy and Breastfeeding: Not recommended for use during pregnancy, particularly if combined with ribavirin. Women of childbearing age should use effective contraception during and after treatment.
  • Drug Interactions: Sofosbuvir and Velpatasvir can interact with other medications, such as antacids, St. John’s Wort, rifampin, and certain anticonvulsants. Always inform your healthcare provider about all medications and supplements you are taking.
  • Liver Function: Regular liver function tests are recommended to monitor the effectiveness of the treatment.
  • Do Not Use With Amiodarone: The combination can cause life-threatening bradycardia when used with amiodarone.

Managing Side Effects:

  • Common Side Effects: Headache, fatigue, nausea, and insomnia.
  • Serious Side Effects: Symptoms of liver problems (yellowing of the skin or eyes, dark urine), chest pain, or shortness of breath. Seek immediate medical attention if these symptoms occur.
  • Management Tips: For mild side effects, drink plenty of water, get adequate rest, and take medications like acetaminophen (as advised by your healthcare provider). If side effects persist, consult your doctor.

Guidelines:

  • Continue taking Sofosbuvir and Velpatasvir for the full duration of the treatment course, even if you start feeling better.
  • Avoid alcohol, as it can increase the risk of liver damage.
  • Regular blood tests are necessary to monitor liver function and treatment efficacy.
  • Do not take this medication along with other drugs for Hepatitis C unless directed by a healthcare provider.

Frequently Asked Questions (FAQs)

  1. What is Sofosbuvir and Velpatasvir used for?

    • This combination is used for the treatment of chronic Hepatitis C infection across all genotypes (genotypes 1 to 6). It is effective for patients both with and without cirrhosis.
  2. Can Sofosbuvir and Velpatasvir cure Hepatitis C?

    • Yes, when taken as directed, this combination can achieve a sustained virologic response (SVR), which is considered a "functional cure" for Hepatitis C.
  3. What are the common side effects of Sofosbuvir and Velpatasvir?

    • The most common side effects include headache, fatigue, and nausea. These symptoms are usually mild and improve over time.
  4. Is it safe to use Sofosbuvir and Velpatasvir during pregnancy?

    • It is not recommended during pregnancy, especially when used with ribavirin. Women should use effective contraception during and for 6 months after treatment.
  5. Can I drink alcohol while taking Sofosbuvir and Velpatasvir?

    • Avoid alcohol during treatment, as it can increase the risk of liver damage and affect treatment outcomes.
  6. How long is the treatment duration?

    • The standard treatment duration is 12 weeks, but this may vary depending on the presence of cirrhosis or other health conditions.
  7. What should I do if I miss a dose?

    • If you miss a dose, take it as soon as you remember, but do not double the next dose to make up for the missed one.
  8. Can I take antacids with Sofosbuvir and Velpatasvir?

    • Avoid taking antacids within 4 hours of taking Sofosbuvir and Velpatasvir, as they can reduce the absorption and effectiveness of the medication.

Quick Links:

GenericFERRO-GRAD Iron & Vitamin C 90 Tablets

FERRO-GRAD Iron & Vitamin C 90 Tablets

Active Ingredient: ferrous sulfate 325, sodium ascorbate 562.4

Unit: 90 tablets | Pack: Tablet

USD $69.95

GenericMaltofer Oral Iron 100mg 100 Tablets

Maltofer Oral Iron 100mg 100 Tablets

Active Ingredient: crospovidone, hydroxypropyl cellulose, hypromellose, iron oxide red, iron oxide yellow, macrogol 6000, magnesium stearate, cellulose - microcrystalline and titaniu

Unit: 100mg | Pack: Tablet

USD $78.99

GenericEve Wellness A Juicy Dose Of Iron 30 Capsules

Eve Wellness A Juicy Dose Of Iron 30 Capsules

Active Ingredient: Ingredients (quantity per serve) Iron (as glycinate (Ferrochel®).........................................24mg Colecalciterol (Vitamin D-3).............................................25mcg

Unit: 30 capsules | Pack: Capsule

USD $26.95

GenericSwisse Ultiboost Iron 30 Tablets

Swisse Ultiboost Iron 30 Tablets

Active Ingredient: Iron (from iron amino acid chelate) 20 mg; Vitamin C (ascorbic acid from calcium ascorbate dihydrate) 16.52 mg; Vitamin B6 (pyridoxine from pyridoxine hydrochloride) 8.22 mg; Betacarotene 1 mg; spirulina (Arthrospira pla

Unit: 30 tablets | Pack: Tablet

USD $15.99

BrandSudocrem Healing Cream 100g Tube

Sudocrem Healing Cream 100g Tube

Active Ingredient: Zinc Oxide 15.29% w/w

Unit: 100g | Pack: Cream

USD $18.99

BrandBioCeuticals Glutathione 60 Capsules

BioCeuticals Glutathione 60 Capsules

Active Ingredient: No animal product - suitable for vegans

Unit: 60 capsules | Pack: Capsule

USD $56.49

BrandBioceuticals ArmaForce 60 Tablets

Bioceuticals ArmaForce 60 Tablets

Active Ingredient: Herbals: Andrographis paniculata (andrographis) extract dry conc. AP-Bio® 178.6 mg equiv. to dry leaf 2.5 mg std. to andrographolides 62.5 mg Olea europaea (olive) extract dry conc. 150 mg equiv. to dry leaf 750 mg std. to oleuropein

Unit: 60 tablets | Pack: Tablet

USD $42.49

BrandBioCeuticals Iron Sustain 30 Tablets

BioCeuticals Iron Sustain 30 Tablets

Active Ingredient: Nutrients: Iron (II) glycinate (bisglycinate) Ferrochel™ (iron 24 mg) 88.8 mg Ascorbic acid (vitamin C) 200 mg Pyridoxal 5-phosphate monohydrate (P5P) (active vitamin B6) 24.4 mg (pyridoxine, vitamin B6 15 mg) Levomefolate calcium 12

Unit: 30 tablets | Pack: Tablet

USD $21.49

More from Antivirals/HIV

RxGeneric ATRIPLA

ATRIPLA

Active Ingredient: Efavirenz/Lamivudine/Tenofovir

Unit: 30 | Pack: Other

USD $357.23

RxGeneric ATRIPLA 600/200/300

ATRIPLA 600/200/300

Active Ingredient: Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate

Unit: 30 | Pack: Other

USD $180.49

RxGeneric BARACLUDE

BARACLUDE

Active Ingredient: Entecavir

Unit: 10 | Pack: Other

USD $88.79

RxGeneric Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) 50mg/200mg/25mg x 30 Tablets

Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) 50mg/200mg/25mg x 30 Tablets

Active Ingredient: Bictegravir 50mg, Emtricitabine 200mg and Tenofovir Alafenamide 25mg

Unit: 30 | Pack: Tablet

USD $216.00

RxGeneric COMBIVIR

COMBIVIR

Active Ingredient: Lamivudine / Zidovudine

Unit: 120 | Pack: Other

USD $137.27

RxGeneric CRIXIVAN

CRIXIVAN

Active Ingredient: Indinavir

Unit: 30 | Pack: Other

USD $43.54

RxGeneric Daklinza (Daclatasvir) 60mg x 28 Tablets

Daklinza (Daclatasvir) 60mg x 28 Tablets

Active Ingredient: Daclatasvir

Unit: 28 | Pack: Tablet

USD $162.00

RxGeneric DUREZOL (Difluprednate) 0.05% Eye Drop

DUREZOL (Difluprednate) 0.05% Eye Drop

Active Ingredient: Difluprednate

Unit: 1 | Pack: eye_drops

USD $16.80

RxGeneric EPIVIR

EPIVIR

Active Ingredient: Lamivudine

Unit: 30 | Pack: Other

USD $25.50

RxGeneric FAMVIR

FAMVIR

Active Ingredient: Famciclovir

Unit: 30 | Pack: Other

USD $56.92

Health Guides

Health Guides Related to Resof Total (Sofosbuvir & Velpatasvir) 400/100mg 28 Tablets

Medication-Related Dry Mouth: Causes and Safe Relief

Nov 06, 2026

Medication-Related Dry Mouth: Causes and Safe Relief

Medication dry mouth happens when a drug reduces saliva production or alters the sensation of moisture. Anticholinergic effects are a common cause, and management usually combines a medication review, moisture replacement and tooth protection. Persistent dryness can make eating or speaking difficult

Blood Pressure Medication Dizziness on Standing

Nov 05, 2026

Blood Pressure Medication Dizziness on Standing

Blood pressure medicines can cause dizziness on standing because they reduce the body's ability to maintain pressure against gravity. The resulting drop can briefly reduce blood flow to the brain, a condition called orthostatic hypotension. Blood pressure medication dizziness often appears after t

Biotin Blood Test Interference: Thyroid and Heart Risks

Nov 04, 2026

Biotin Blood Test Interference: Thyroid and Heart Risks

Biotin supplements can interfere with thyroid and heart blood tests, producing falsely high or unexpectedly low results. This interference affects certain laboratory methods rather than the actual hormone or cardiac-marker concentration being measured. The greatest danger is a falsely low troponin r

ADHD Medication Monitoring: Appetite, Sleep, Blood Pressure

Nov 02, 2026

ADHD Medication Monitoring: Appetite, Sleep, Blood Pressure

ADHD medication monitoring tracks blood pressure, heart rate, body mass, appetite and sleep before treatment, during dose adjustments and throughout long-term care. For adults, NICE recommends pulse and blood pressure checks before and after each dose change, then every six months. The aim is to pre

Baricitinib Safety: Risks, Lab Tests, and When to Call

Nov 01, 2026

Baricitinib Safety: Risks, Lab Tests, and When to Call

Baricitinib safety depends on infection screening, blood tests, and prompt evaluation of new symptoms. The main concerns are serious infections, shingles, blood clots, cancer, and cardiovascular events. Blood counts, liver and kidney function, and cholesterol help guide treatment. Historical rheumat

Medication Redosing After Vomiting: When to Repeat a Dose

Oct 31, 2026

Medication Redosing After Vomiting: When to Repeat a Dose

Whether to repeat a dose of an oral medication depends on the medicine, formulation, and elapsed time. Vomiting within 15 minutes or seeing an intact tablet can justify considering a replacement; after an hour, another dose is usually unnecessary. These are general timing guides, not permission to r

Tacrolimus Monitoring: Why Blood Levels and Timing Matter

Oct 30, 2026

Tacrolimus Monitoring: Why Blood Levels and Timing Matter

Tacrolimus monitoring measures the tacrolimus level in whole blood to help balance organ rejection prevention against drug-related toxic effects. The result is useful only when interpreted against the dose and formulation. A routine trough sample is collected immediately before the next dose, usuall

Serotonin Syndrome: Warning Signs and Drug Triggers

Oct 29, 2026

Serotonin Syndrome: Warning Signs and Drug Triggers

Serotonin syndrome is a potentially life-threatening drug reaction caused by excessive serotonin activity. Fever, confusion, and muscle jerking after a medicine change require urgent medical assessment. Symptoms often begin within hours, particularly when medicines with overlapping serotonin effects

Lithium Monitoring: Blood Tests and Safety Checks

Oct 28, 2026

Lithium Monitoring: Blood Tests and Safety Checks

Lithium monitoring combines timed blood levels with kidney, thyroid, and calcium tests to keep bipolar treatment effective and reduce toxicity risk. Testing starts before treatment and continues throughout it. Lithium has a narrow therapeutic index, so relatively small changes in blood concentration

BPH Medications: Alpha Blockers vs. 5-ARIs

Oct 27, 2026

BPH Medications: Alpha Blockers vs. 5-ARIs

Benign prostatic hyperplasia (BPH) is a noncancerous enlarged prostate. Alpha blockers ease urinary symptoms by relaxing muscle around the outlet, often within days to weeks. 5-alpha-reductase inhibitors (5-ARIs) shrink the prostate gradually and can reduce the risks of urinary retention and surgery